Yongmei Yin

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 48

Top Venues

Science advances

Nature medicine

Cancers

Cancer communications (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Jie Mei, Yun Cai, Hongjun Zhu, Ying Jiang, Ziyi Fu, Junying Xu, Lingyan Chen, Kai Yang, Jinlu Zhao, Chenghu Song, Yan Zhang, Wenjun Mao, Yongmei Yin
High B7-H3 expression with low PD-L1 expression identifies armored-cold tumors in triple-negative breast cancer. NPJ breast cancer 10 (1) (2024)
Ningjun Duan, Yijia Hua, Xueqi Yan, Yaozhou He, Tianyu Zeng, Jue Gong, Ziyi Fu, Wei Li, Yongmei Yin
An Imbalance in Histone Modifiers Induces tRNA-Cys-GCA Overexpression and tRF-27 Accumulation by Attenuating Promoter H3K27me3 in Primary Trastuzumab-Resistant Breast Cancer. Cancers 16 (6) (2024)
Zefei Jiang, Quchang Ouyang, Tao Sun, Qingyuan Zhang, Yuee Teng, Jiuwei Cui, Hai-Bo Wang, Yongmei Yin, Xiao-Jia Wang, Xin Zhou, Yongsheng Wang, Gang Sun, Jingfen Wang, Lili Zhang, Jin Yang, Jun Qian, Min Yan, Xinlan Liu, Tienan Yi, Ying Cheng, Man Li, Aimin Zang, Shu-Sen Wang, Chuan Wang, Xinhong Wu, Jing Cheng, Hui Li, Ying Lin, Cuizhi Geng, Kangsheng Gu, Chunwei Xie, Huihua Xiong, Xiaohong Wu, Junlan Yang, Qingshan Li, Yi-Ding Chen, Fanfan Li, Anqin Zhang, Yongqiang Zhang, Yudong Wu, Jianyun Nie, Qiang Liu, Kun Wang, Xueli Mo, Lilin Chen, Yue-Yin Pan, Peifen Fu, Helong Zhang, Danmei Pang, Yuan Sheng, Yunwei Han, Hongxia Wang, Shundong Cang, Xianming Luo, Wenbo Yu, Rong Deng, Chaoqiang Yang, Patricia Keegan
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial. Nature medicine 30 (1) (2024)
Jie Mei, Yun Cai, Hongjun Zhu, Ying Jiang, Ziyi Fu, Junying Xu, Lingyan Chen, Kai Yang, Jinlu Zhao, Chenghu Song, Yan Zhang, Wenjun Mao, Yongmei Yin
High B7-H3 expression with low PD-L1 expression identifies armored-cold tumors in triple-negative breast cancer. NPJ breast cancer 10 (1) (2024)
Ningjun Duan, Yijia Hua, Xueqi Yan, Yaozhou He, Tianyu Zeng, Jue Gong, Ziyi Fu, Wei Li, Yongmei Yin
Unveiling Alterations of Epigenetic Modifications and Chromatin Architecture Leading to Lipid Metabolic Reprogramming during the Evolutionary Trastuzumab Adaptation of HER2-Positive Breast Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (18) (2024)
Zefei Jiang, Quchang Ouyang, Tao Sun, Qingyuan Zhang, Yuee Teng, Jiuwei Cui, Hai-Bo Wang, Yongmei Yin, Xiao-Jia Wang, Xin Zhou, Yongsheng Wang, Gang Sun, Jingfen Wang, Lili Zhang, Jin Yang, Jun Qian, Min Yan, Xinlan Liu, Tienan Yi, Ying Cheng, Man Li, Aimin Zang, Shu-Sen Wang, Chuan Wang, Xinhong Wu, Jing Cheng, Hui Li, Ying Lin, Cuizhi Geng, Kangsheng Gu, Chunwei Xie, Huihua Xiong, Xiaohong Wu, Junlan Yang, Qingshan Li, Yi-Ding Chen, Fanfan Li, Anqin Zhang, Yongqiang Zhang, Yudong Wu, Jianyun Nie, Qiang Liu, Kun Wang, Xueli Mo, Lilin Chen, Yue-Yin Pan, Peifen Fu, Helong Zhang, Danmei Pang, Yuan Sheng, Yunwei Han, Hongxia Wang, Shundong Cang, Xianming Luo, Wenbo Yu, Rong Deng, Chaoqiang Yang, Patricia Keegan
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial. Nature medicine 30 (1) (2024)
Jie Mei, Yun Cai, Rui Xu, Qing Li, Jiahui Chu, Zhiwen Luo, Yaying Sun, Yuxin Shi, Junying Xu, Di Li, Shuai Liang, Ying Jiang, Jiayu Liu, Zhiwen Qian, Jiaofeng Zhou, Mengyun Wan, Yunlong Yang, Yichao Zhu, Yan Zhang, Yongmei Yin
Conserved immuno-collagenic subtypes predict response to immune checkpoint blockade. Cancer communications (London, England) 44 (5) (2024)
Fei Qu, Rongrong Lu, Qian Liu, Xuefang Wu, Xiang Huang, Yongmei Yin, Wei Li
Antibody-drug conjugates transform the outcome of individuals with low-HER2-expression advanced breast cancer. Cancer 130 (S8) (2024)
Ningjun Duan, Yijia Hua, Xueqi Yan, Yaozhou He, Tianyu Zeng, Jue Gong, Ziyi Fu, Wei Li, Yongmei Yin
Unveiling Alterations of Epigenetic Modifications and Chromatin Architecture Leading to Lipid Metabolic Reprogramming during the Evolutionary Trastuzumab Adaptation of HER2-Positive Breast Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (18) (2024)
Jie Mei, Yun Cai, Rui Xu, Qing Li, Jiahui Chu, Zhiwen Luo, Yaying Sun, Yuxin Shi, Junying Xu, Di Li, Shuai Liang, Ying Jiang, Jiayu Liu, Zhiwen Qian, Jiaofeng Zhou, Mengyun Wan, Yunlong Yang, Yichao Zhu, Yan Zhang, Yongmei Yin
Conserved immuno-collagenic subtypes predict response to immune checkpoint blockade. Cancer communications (London, England) 44 (5) (2024)
Zefei Jiang, Quchang Ouyang, Tao Sun, Qingyuan Zhang, Yuee Teng, Jiuwei Cui, Hai-Bo Wang, Yongmei Yin, Xiao-Jia Wang, Xin Zhou, Yongsheng Wang, Gang Sun, Jingfen Wang, Lili Zhang, Jin Yang, Jun Qian, Min Yan, Xinlan Liu, Tienan Yi, Ying Cheng, Man Li, Aimin Zang, Shu-Sen Wang, Chuan Wang, Xinhong Wu, Jing Cheng, Hui Li, Ying Lin, Cuizhi Geng, Kangsheng Gu, Chunwei Xie, Huihua Xiong, Xiaohong Wu, Junlan Yang, Qingshan Li, Yi-Ding Chen, Fanfan Li, Anqin Zhang, Yongqiang Zhang, Yudong Wu, Jianyun Nie, Qiang Liu, Kun Wang, Xueli Mo, Lilin Chen, Yue-Yin Pan, Peifen Fu, Helong Zhang, Danmei Pang, Yuan Sheng, Yunwei Han, Hongxia Wang, Shundong Cang, Xianming Luo, Wenbo Yu, Rong Deng, Chaoqiang Yang, Patricia Keegan
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial. Nature medicine 30 (1) (2024)
Zefei Jiang, Quchang Ouyang, Tao Sun, Qingyuan Zhang, Yuee Teng, Jiuwei Cui, Hai-Bo Wang, Yongmei Yin, Xiao-Jia Wang, Xin Zhou, Yongsheng Wang, Gang Sun, Jingfen Wang, Lili Zhang, Jin Yang, Jun Qian, Min Yan, Xinlan Liu, Tienan Yi, Ying Cheng, Man Li, Aimin Zang, Shu-Sen Wang, Chuan Wang, Xinhong Wu, Jing Cheng, Hui Li, Ying Lin, Cuizhi Geng, Kangsheng Gu, Chunwei Xie, Huihua Xiong, Xiaohong Wu, Junlan Yang, Qingshan Li, Yi-Ding Chen, Fanfan Li, Anqin Zhang, Yongqiang Zhang, Yudong Wu, Jianyun Nie, Qiang Liu, Kun Wang, Xueli Mo, Lilin Chen, Yue-Yin Pan, Peifen Fu, Helong Zhang, Danmei Pang, Yuan Sheng, Yunwei Han, Hongxia Wang, Shundong Cang, Xianming Luo, Wenbo Yu, Rong Deng, Chaoqiang Yang, Patricia Keegan
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial. Nature medicine 30 (1) (2024)
Ningjun Duan, Yijia Hua, Xueqi Yan, Yaozhou He, Tianyu Zeng, Jue Gong, Ziyi Fu, Wei Li, Yongmei Yin
Unveiling Alterations of Epigenetic Modifications and Chromatin Architecture Leading to Lipid Metabolic Reprogramming during the Evolutionary Trastuzumab Adaptation of HER2-Positive Breast Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Zefei Jiang, Quchang Ouyang, Tao Sun, Qingyuan Zhang, Yuee Teng, Jiuwei Cui, Hai-Bo Wang, Yongmei Yin, Xiao-Jia Wang, Xin Zhou, Yongsheng Wang, Gang Sun, Jingfen Wang, Lili Zhang, Jin Yang, Jun Qian, Min Yan, Xinlan Liu, Tienan Yi, Ying Cheng, Man Li, Aimin Zang, Shu-Sen Wang, Chuan Wang, Xinhong Wu, Jing Cheng, Hui Li, Ying Lin, Cuizhi Geng, Kangsheng Gu, Chunwei Xie, Huihua Xiong, Xiaohong Wu, Junlan Yang, Qingshan Li, Yi-Ding Chen, Fanfan Li, Anqin Zhang, Yongqiang Zhang, Yudong Wu, Jianyun Nie, Qiang Liu, Kun Wang, Xueli Mo, Lilin Chen, Yue-Yin Pan, Peifen Fu, Helong Zhang, Danmei Pang, Yuan Sheng, Yunwei Han, Hongxia Wang, Shundong Cang, Xianming Luo, Wenbo Yu, Rong Deng, Chaoqiang Yang, Patricia Keegan
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial. Nature medicine (2024)
Zefei Jiang, Quchang Ouyang, Tao Sun, Qingyuan Zhang, Yuee Teng, Jiuwei Cui, Hai-Bo Wang, Yongmei Yin, Xiao-Jia Wang, Xin Zhou, Yongsheng Wang, Gang Sun, Jingfen Wang, Lili Zhang, Jin Yang, Jun Qian, Min Yan, Xinlan Liu, Tienan Yi, Ying Cheng, Man Li, Aimin Zang, Shu-Sen Wang, Chuan Wang, Xinhong Wu, Jing Cheng, Hui Li, Ying Lin, Cuizhi Geng, Kangsheng Gu, Chunwei Xie, Huihua Xiong, Xiaohong Wu, Junlan Yang, Qingshan Li, Yi-Ding Chen, Fanfan Li, Anqin Zhang, Yongqiang Zhang, Yudong Wu, Jianyun Nie, Qiang Liu, Kun Wang, Xueli Mo, Lilin Chen, Yue-Yin Pan, Peifen Fu, Helong Zhang, Danmei Pang, Yuan Sheng, Yunwei Han, Hongxia Wang, Shundong Cang, Xianming Luo, Wenbo Yu, Rong Deng, Chaoqiang Yang, Patricia Keegan
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial. Nature medicine 30 (1) (2024)
Fei Qu, Rongrong Lu, Qian Liu, Xuefang Wu, Xiang Huang, Yongmei Yin, Wei Li
Antibody-drug conjugates transform the outcome of individuals with low-HER2-expression advanced breast cancer. Cancer 130 (S8) (2024)
Ningjun Duan, Yijia Hua, Xueqi Yan, Yaozhou He, Tianyu Zeng, Jue Gong, Ziyi Fu, Wei Li, Yongmei Yin
Unveiling Alterations of Epigenetic Modifications and Chromatin Architecture Leading to Lipid Metabolic Reprogramming during the Evolutionary Trastuzumab Adaptation of HER2-Positive Breast Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (18) (2024)
Hai Shi, Tianyu Zeng, Qizhi Liang, Jiahua Yang, Ruoyi Chen, Shuai Wu, Ningjun Duan, Jing Zhao, Genxi Li, Yongmei Yin
Multiplex Assay of Cytokines with Tunable Detection Ranges for the Precise Diagnosis of Breast Cancer. Analytical chemistry 96 (8) (2024)
Ningjun Duan, Yijia Hua, Xueqi Yan, Yaozhou He, Tianyu Zeng, Jue Gong, Ziyi Fu, Wei Li, Yongmei Yin
An Imbalance in Histone Modifiers Induces tRNA-Cys-GCA Overexpression and tRF-27 Accumulation by Attenuating Promoter H3K27me3 in Primary Trastuzumab-Resistant Breast Cancer. Cancers 16 (6) (2024)
Xi Wang, Shengnan Bao, Mengping Jiang, Xian Zou, Yongmei Yin
Clinical, pathological and gene expression profiling of estrogen receptor discordance in breast cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Fei Qu, Rongrong Lu, Qian Liu, Xuefang Wu, Xiang Huang, Yongmei Yin, Wei Li
Antibody-drug conjugates transform the outcome of individuals with low-HER2-expression advanced breast cancer. Cancer (2024)
Hai Shi, Tianyu Zeng, Qizhi Liang, Jiahua Yang, Ruoyi Chen, Shuai Wu, Ningjun Duan, Jing Zhao, Genxi Li, Yongmei Yin
Multiplex Assay of Cytokines with Tunable Detection Ranges for the Precise Diagnosis of Breast Cancer. Analytical chemistry 96 (8) (2024)
Hai Shi, Tianyu Zeng, Qizhi Liang, Jiahua Yang, Ruoyi Chen, Shuai Wu, Ningjun Duan, Jing Zhao, Genxi Li, Yongmei Yin
Multiplex Assay of Cytokines with Tunable Detection Ranges for the Precise Diagnosis of Breast Cancer. Analytical chemistry 96 (8) (2024)
Hai Shi, Tianyu Zeng, Qizhi Liang, Jiahua Yang, Ruoyi Chen, Shuai Wu, Ningjun Duan, Jing Zhao, Genxi Li, Yongmei Yin
Multiplex Assay of Cytokines with Tunable Detection Ranges for the Precise Diagnosis of Breast Cancer. Analytical chemistry (2024)
Jie Mei, Yun Cai, Rui Xu, Qing Li, Jiahui Chu, Zhiwen Luo, Yaying Sun, Yuxin Shi, Junying Xu, Di Li, Shuai Liang, Ying Jiang, Jiayu Liu, Zhiwen Qian, Jiaofeng Zhou, Mengyun Wan, Yunlong Yang, Yichao Zhu, Yan Zhang, Yongmei Yin
Conserved immuno-collagenic subtypes predict response to immune checkpoint blockade. Cancer communications (London, England) (2024)
Jie Mei, Yun Cai, Rui Xu, Qing Li, Jiahui Chu, Zhiwen Luo, Yaying Sun, Yuxin Shi, Junying Xu, Di Li, Shuai Liang, Ying Jiang, Jiayu Liu, Zhiwen Qian, Jiaofeng Zhou, Mengyun Wan, Yunlong Yang, Yichao Zhu, Yan Zhang, Yongmei Yin
Conserved immuno-collagenic subtypes predict response to immune checkpoint blockade. Cancer communications (London, England) 44 (5) (2024)
Chunxiao Sun, Xiang Huang, Jun Li, Ziyi Fu, Yijia Hua, Tianyu Zeng, Yaozhou He, Ningjun Duan, Fan Yang, Yan Liang, Hao Wu, Wei Li, Yuchen Zhang, Yongmei Yin
Exosome-Transmitted tRF-16-K8J7K1B Promotes Tamoxifen Resistance by Reducing Drug-Induced Cell Apoptosis in Breast Cancer. Cancers 15 (3) (2023)
Ziyi Fu, Siqi Chen, Yueming Zhu, Donghong Zhang, Ping Xie, Qiao Jiao, Junlong Chi, Shipeng Xu, Yifan Xue, Xinghua Lu, Xinxin Song, Massimo Cristofanilli, William J Gradishar, Kevin Kalinsky, Yongmei Yin, Bin Zhang, Yong Wan
Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity. Science advances 9 (1) (2023)
Ziyi Fu, Siqi Chen, Yueming Zhu, Donghong Zhang, Ping Xie, Qiao Jiao, Junlong Chi, Shipeng Xu, Yifan Xue, Xinghua Lu, Xinxin Song, Massimo Cristofanilli, William J Gradishar, Kevin Kalinsky, Yongmei Yin, Bin Zhang, Yong Wan
Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity. Science advances 9 (1) (2023)
Ziyi Fu, Siqi Chen, Yueming Zhu, Donghong Zhang, Ping Xie, Qiao Jiao, Junlong Chi, Shipeng Xu, Yifan Xue, Xinghua Lu, Xinxin Song, Massimo Cristofanilli, William J Gradishar, Kevin Kalinsky, Yongmei Yin, Bin Zhang, Yong Wan
Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity. Science advances 9 (1) (2023)
Chunxiao Sun, Xiang Huang, Jun Li, Ziyi Fu, Yijia Hua, Tianyu Zeng, Yaozhou He, Ningjun Duan, Fan Yang, Yan Liang, Hao Wu, Wei Li, Yuchen Zhang, Yongmei Yin
Exosome-Transmitted tRF-16-K8J7K1B Promotes Tamoxifen Resistance by Reducing Drug-Induced Cell Apoptosis in Breast Cancer. Cancers 15 (3) (2023)
Ziyi Fu, Siqi Chen, Yueming Zhu, Donghong Zhang, Ping Xie, Qiao Jiao, Junlong Chi, Shipeng Xu, Yifan Xue, Xinghua Lu, Xinxin Song, Massimo Cristofanilli, William J Gradishar, Kevin Kalinsky, Yongmei Yin, Bin Zhang, Yong Wan
Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity. Science advances 9 (1) (2023)
Ziyi Fu, Siqi Chen, Yueming Zhu, Donghong Zhang, Ping Xie, Qiao Jiao, Junlong Chi, Shipeng Xu, Yifan Xue, Xinghua Lu, Xinxin Song, Massimo Cristofanilli, William J Gradishar, Kevin Kalinsky, Yongmei Yin, Bin Zhang, Yong Wan
Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity. Science advances 9 (1) (2023)
Ziyi Fu, Siqi Chen, Yueming Zhu, Donghong Zhang, Ping Xie, Qiao Jiao, Junlong Chi, Shipeng Xu, Yifan Xue, Xinghua Lu, Xinxin Song, Massimo Cristofanilli, William J Gradishar, Kevin Kalinsky, Yongmei Yin, Bin Zhang, Yong Wan
Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity. Science advances 9 (1) (2023)
Ziyi Fu, Siqi Chen, Yueming Zhu, Donghong Zhang, Ping Xie, Qiao Jiao, Junlong Chi, Shipeng Xu, Yifan Xue, Xinghua Lu, Xinxin Song, Massimo Cristofanilli, William J Gradishar, Kevin Kalinsky, Yongmei Yin, Bin Zhang, Yong Wan
Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity. Science advances 9 (1) (2023)
Xinyu Wu, Nan Jin, Hongfei Gao, Min Yan, Qianjun Chen, Tao Sun, Chunfang Hao, Yanxia Zhao, Xinhua Han, Yueyin Pan, Xiang Huang, Wei Li, Kun Wang, Yongmei Yin
Effectiveness and Safety of Palbociclib Plus Endocrine Therapy in Patients with Advanced Breast Cancer: A Multi-Center Study in China. Cancers 15 (17) (2023)
Yijia Hua, Wei Li, Nan Jin, Dongyan Cai, Jie Sun, Chunxiao Sun, Fan Yang, Xinyu Wu, Xiang Huang, Bi-Yun Wang, Yongmei Yin
Treatment with pyrotinib-based therapy in lapatinib-resistant HER2-positive metastatic breast cancer: a multicenter real-world study. Therapeutic advances in medical oncology 14 (2022)
Caiyun Yan, Jianling Bai, Shengnan Bao, Yiqin Xia, Hao Yu, Yongmei Yin
Which Has a Greater Impact on the Recurrence in Young Breast Cancer Patients: Recent Childbirth or Recent Breastfeeding? The breast journal 2022 (2022)
Ya Cao, Xiaomeng Yu, Tianyu Zeng, Ziyi Fu, Yingyan Zhao, Beibei Nie, Jing Zhao, Yongmei Yin, Genxi Li
Molecular Characterization of Exosomes for Subtype-Based Diagnosis of Breast Cancer. Journal of the American Chemical Society 144 (30) (2022)
Xueqi Yan, Yaozhou He, Shikun Yang, Tianyu Zeng, Yijia Hua, Shengnan Bao, Fan Yang, Ningjun Duan, Chunxiao Sun, Yan Liang, Ziyi Fu, Xiang Huang, Wei Li, Yongmei Yin
A positive feedback loop: RAD18-YAP-TGF-β between triple-negative breast cancer and macrophages regulates cancer stemness and progression. Cell death discovery 8 (1) (2022)
Tianyu Zeng, Chunxiao Sun, Yan Liang, Fan Yang, Xueqi Yan, Shengnan Bao, Yucheng Zhang, Xiang Huang, Ziyi Fu, Wei Li, Yongmei Yin
A Real-World Multicentre Retrospective Study of Low-Dose Apatinib for Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer. Cancers 14 (17) (2022)
Yan Liang, Chao Qian, Yinghong Xie, Xiang Huang, Junjie Chen, Yanlin Ren, Ziyi Fu, Yongfei Li, Tianyu Zeng, Fan Yang, Jianwei Zhou, Wei Li, Yongmei Yin, Changqing Wang
JWA suppresses proliferation in trastuzumab-resistant breast cancer by downregulating CDK12. Cell death discovery 7 (1) (2021)
Shengnan Bao, Mengping Jiang, Xi Wang, Yijia Hua, Tianyu Zeng, Yiqi Yang, Fan Yang, Xueqi Yan, Chunxiao Sun, Mengzhu Yang, Ziyi Fu, Xiang Huang, Jun Li, Hao Wu, Wei Li, Jin-Hai Tang, Yongmei Yin
Nonmetastatic breast cancer patients subsequently developing second primary malignancy: A population-based study. Cancer medicine 10 (23) (2021)
Xueqi Yan, Yinghong Xie, Fan Yang, Yijia Hua, Tianyu Zeng, Chunxiao Sun, Mengzhu Yang, Xiang Huang, Hao Wu, Ziyi Fu, Wei Li, Shiping Jiao, Yongmei Yin
Comprehensive description of the current breast cancer microenvironment advancements via single-cell analysis. Journal of experimental & clinical cancer research : CR 40 (1) (2021)
Tianyu Zeng, Yijia Hua, Chunxiao Sun, Yuchen Zhang, Fan Yang, Mengzhu Yang, Yiqi Yang, Jun Li, Xiang Huang, Hao Wu, Ziyi Fu, Wei Li, Yongmei Yin
Relationship between tRNA-derived fragments and human cancers. International journal of cancer 147 (11) (2020)
Xiaorong Ding, Yumei Li, Jun Li, Yongmei Yin
OSW-1 inhibits tumor growth and metastasis by NFATc2 on triple-negative breast cancer. Cancer medicine 9 (15) (2020)
Fan Yang, Xiang Huang, Chunxiao Sun, Jianbin Li, Biyun Wang, Min Yan, Feng Jin, Haibo Wang, Jin Zhang, Peifen Fu, Tianyu Zeng, Jian Wang, Wei Li, Yongfei Li, Mengzhu Yang, Jun Li, Hao Wu, Ziyi Fu, Yongmei Yin, Zefei Jiang
Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population. BMC cancer 20 (1) (2020)
Fan Yang, Ziyi Fu, Mengzhu Yang, Chunxiao Sun, Yongfei Li, Jiahui Chu, Yanhong Zhang, Wei Li, Xiang Huang, Jun Li, Hao Wu, Xiaorong Ding, Yongmei Yin
Expression pattern of microRNAs related with response to trastuzumab in breast cancer. Journal of cellular physiology (2019)

Yongmei Yin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yongmei Yin